European equities traded in the US as American depositary receipts were edging lower late Wednesday morning, declining 0.18% to 1,435.51 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by biopharmaceutical company argenx (ARGX) and telecommunications operator Telefonica (TEF), which rose 1.2% and 0.9% respectively. They were followed by biopharmaceutical company Calliditas Therapeutics (CALT) and financial services company Banco Bilbao Vizcaya Argentaria (BBVA), which were up 0.7% and 0.4% respectively.
The decliners from continental Europe were led by biotech firm BioNTech (BNTX) and telecommunications operator VEON (VEON), which fell 4.4% and 2.9% respectively. They were followed by semiconductor company Sequans Communications (SQNS) and biopharmaceutical company DBV Technologies (DBVT), which were down 2.3% and 1.6% respectively.
From the UK and Ireland, the gainers were led by biopharmaceutical company Mereo BioPharma Group (MREO) and biotech firm Autolus Therapeutics (AUTL), which advanced 8.1% and 2.6% respectively. They were followed by biopharmaceutical company Akari Therapeutics (AKTX) and cruise line operator Carnival (CUK), which increased 2.7% and 2.1% respectively.
The decliners from the UK and Ireland were led by biopharmaceutical companies TC Biopharm (TCBP) and NuCana (NCNA), which dropped 4.7% and 1.9% respectively. They were followed by software firm Endava (DAVA) and biopharmaceutical company Biodexa Pharmaceuticals (BDRX), which lost 3.4% and 1.2% respectively.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。